Yüklüyor......
Understanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer
The management of metastatic colorectal cancer substantially improved over the last 10 years and median overall survival of patients might exceed 30 months. The selection of an effective first-line treatment represents a crucial point in order to achieve good outcome results. In the last years, the...
Kaydedildi:
| Yayımlandı: | Crit Rev Oncol Hematol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4799732/ https://ncbi.nlm.nih.gov/pubmed/26850575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.critrevonc.2016.01.020 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|